Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-05-14 12:15 pm Purchase | 2025-03-31 | 13G | Avidity Biosciences, Inc. RNA | JANUS HENDERSON GROUP PLC JHG | 11,461,633 9.500% | 4,408,623 (+62.51%) | Filing History |
| 2025-05-12 10:44 am Purchase | 2025-03-31 | 13G | Avidity Biosciences, Inc. RNA | WELLINGTON MANAGEMENT GROUP LLP | 9,684,556 8.100% | 2,653,607 (+37.74%) | Filing History |
| 2025-05-12 10:24 am Purchase | 2025-03-31 | 13G | Avidity Biosciences, Inc. RNA | FMR LLC | 15,615,064 13.000% | 5,210,968 (+50.09%) | Filing History |
| 2025-04-17 09:35 am Purchase | 2025-03-31 | 13G | Avidity Biosciences, Inc. RNA | BlackRock Inc. BLK | 9,042,979 7.500% | 2,546,386 (+39.20%) | Filing History |
| 2025-02-14 11:24 am Purchase | 2024-12-31 | 13G | Avidity Biosciences, Inc. RNA | JANUS HENDERSON GROUP PLC JHG | 7,053,010 5.900% | 7,053,010 (New Position) | Filing History |
| 2024-11-14 5:46 pm Purchase | 2024-09-30 | 13G | Avidity Biosciences, Inc. RNA | RA Capital Management, L.P. | 6,300,408 5.400% | 1,404,449 (+28.69%) | Filing History |
| 2024-11-14 1:22 pm Purchase | 2024-09-30 | 13G | Avidity Biosciences, Inc. RNA | T. Rowe Price Associates, Inc. | 10,633,962 9.000% | 977,110 (+10.12%) | Filing History |
| 2024-11-14 09:39 am Purchase | 2024-09-30 | 13G | Avidity Biosciences, Inc. RNA | AVORO CAPITAL ADVISORS LLC | 9,935,792 8.300% | 9,935,792 (New Position) | Filing History |
| 2024-11-13 4:40 pm Sale | 2024-09-30 | 13G | Avidity Biosciences, Inc. RNA | Cowen Financial Products LLC | 0 0.000% | -5,629,103 (Position Closed) | Filing History |
| 2024-11-13 4:05 pm Unchanged | 2024-09-30 | 13G | Avidity Biosciences, Inc. RNA | BRISTOL MYERS SQUIBB CO BMY | 5,075,304 4.300% | 0 (Unchanged) | Filing History |
| 2024-11-12 1:26 pm Unchanged | 2024-09-30 | 13G | Avidity Biosciences, Inc. RNA | VANGUARD GROUP INC | 9,226,884 7.840% | 0 (Unchanged) | Filing History |
| 2024-11-08 1:56 pm Purchase | 2024-09-30 | 13G | Avidity Biosciences, Inc. RNA | WELLINGTON MANAGEMENT GROUP LLP | 7,030,949 5.970% | 7,030,949 (New Position) | Filing History |
| 2024-11-04 10:22 am Purchase | 2024-09-30 | 13G | Avidity Biosciences, Inc. RNA | VANGUARD GROUP INC | 9,226,884 7.840% | 5,183,705 (+128.21%) | Filing History |
| 2024-08-23 5:46 pm Purchase | 2024-08-22 | 13D | Avidity Biosciences, Inc. RNA | RTW Investments, LP | 12,079,734 9.990% | 2,419,925 (+25.05%) | Filing History |
| 2024-05-06 5:57 pm Purchase | 2024-04-26 | 13G | Avidity Biosciences, Inc. RNA | RA Capital Management, L.P. | 4,895,959 5.100% | 2,441,426 (+99.47%) | Filing History |
| 2024-03-11 1:12 pm Purchase | 2024-02-29 | 13G | Avidity Biosciences, Inc. RNA | T. Rowe Price Associates, Inc. | 9,656,852 12.100% | 2,738,942 (+39.59%) | Filing History |
| 2024-03-01 4:15 pm Purchase | 2024-02-28 | 13D | Avidity Biosciences, Inc. RNA | RTW Investments, LP | 9,659,809 9.990% | 2,958,320 (+44.14%) | Filing History |
| 2024-02-14 5:01 pm Sale | 2023-12-31 | 13G | Avidity Biosciences, Inc. RNA | RA Capital Management, L.P. | 2,454,533 3.300% | -3,000,000 (-55.00%) | Filing History |
| 2024-02-14 10:03 am Purchase | 2023-12-31 | 13G | Avidity Biosciences, Inc. RNA | T. Rowe Price Associates, Inc. | 6,917,910 9.300% | 210,623 (+3.14%) | Filing History |
| 2024-02-13 4:59 pm Purchase | 2023-12-29 | 13G | Avidity Biosciences, Inc. RNA | VANGUARD GROUP INC | 4,043,179 5.460% | 572,553 (+16.50%) | Filing History |